Noemí Waksman de Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noemí Waksman de Torres has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Salazar-Aranda
Departamento de Química Analítica, Facultad de Medicina, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Monterrey 64460, México
9 shared publications - Cecilia Delgado-Montemayor
Universidad Autonóma de Nuevo León
3 shared publications - Graciela Granados-Guzmán
Universidad Autonóma de Nuevo León
3 shared publications - Jonathan Perez-Meseguer
Department of Analytical Chemistry, Faculty of Medicine, Universidad Autónoma de Nuevo Leon, PO Box 2316, Sucursal Tecnológico, Monterrey, NL 64841, Mexico
3 shared publications - Rocío Castro-Ríos
Departamento de Química Analítica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey C.P. 64460, Nuevo León, Mexico
3 shared publications - Alma Leticia Saucedo
Laboratorio Nacional de Investigación y Servicio Agroalimentario y Forestal, Universidad Autónoma Chapingo, km 38.5 Carretera México-Texcoco, Chapingo C.P. 56230, Mexico
2 shared publications
Latest Publications
- Open Access
- 23 May 2024
- Published by Universidad Autonoma de Chihuahua in TECNOCIENCIA Chihuahua
- Vol. 18 (2) , e1392
Diseño y prueba inicial de un instrumento para conocer el uso y consumo de la Stevia rebaudiana en Veracruz-Boca del Río
En México la prevalencia de obesidad en población adulta es superior al 70 %, en particular el estado de Veracruz tiene una de las mayores prevalencias de sobrepeso y obesidad. El consumo de azúcar contribuye al desarrollo de estas enfermedades. Como alternativa los edulcorantes de Stevia rebaudiana (estevia), tienen gran aceptación. El diseño y validación de los instrumentos para recabar información sobre la estevia y sus productos es importante para reducir errores de los datos obtenidos. El objetivo de este trabajo fue diseñar y validar un instrumento sobre el uso y consumo de estevia en la zona conurbada Veracruz-Boca del Rio. Se generó una encuesta inicial con 10 preguntas sobre el consumo y el conocimiento general de la población sobre estevia, cuya validación se realizó por 18 expertos que evaluaron la validez y fiabilidad de cada pregunta. Finalmente, se realizó una prueba inicial de desempeño (n=100) de la encuesta. De los encuestados, 88 % conoce de las propiedades atribuidas a estevia, 69 % padece alguna enfermedad relacionada con el consumo de azúcar y la mayoría percibió beneficios con el consumo de la planta. Se probó el desempeño de un instrumento sobre el uso y consumo de estevia que podría aplicarse a otras áreas urbanas. DOI: https://doi.org/10.54167/tch.v18i2.1392
- 23 May 2024
- Published by Universidad Autonoma de Chihuahua in TECNOCIENCIA Chihuahua
- Vol. 18 (2) , e1392
Open AccessDiseño y prueba inicial de un instrumento para conocer el uso y consumo de la Stevia rebaudiana en Veracruz-Boca del Río
En México la prevalencia de obesidad en población adulta es superior al 70 %, en particular el estado de Veracruz tiene una de las mayores prevalencias de sobrepeso y obesidad. El consumo de azúcar contribuye al desarrollo de estas enfermedades. Como alternativa los edulcorantes de Stevia rebaudiana (estevia), tienen gran aceptación. El diseño y validación de los instrumentos para recabar información sobre la estevia y sus productos es importante para reducir errores de los datos obtenidos. El objetivo de este trabajo fue diseñar y validar un instrumento sobre el uso y consumo de estevia en la zona conurbada Veracruz-Boca del Rio. Se generó una encuesta inicial con 10 preguntas sobre el consumo y el conocimiento general de la población sobre estevia, cuya validación se realizó por 18 expertos que evaluaron la validez y fiabilidad de cada pregunta. Finalmente, se realizó una prueba inicial de desempeño (n=100) de la encuesta. De los encuestados, 88 % conoce de las propiedades atribuidas a estevia, 69 % padece alguna enfermedad relacionada con el consumo de azúcar y la mayoría percibió beneficios con el consumo de la planta. Se probó el desempeño de un instrumento sobre el uso y consumo de estevia que podría aplicarse a otras áreas urbanas. DOI: https://doi.org/10.54167/tch.v18i2.1392
- Open Access
- 7 November 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (11) , 1573
Bioactivity of the Genus Turnera: A Review of the Last 10 Years
Turnera is a genus of plants whose biological activity has been widely studied. The importance of this genus, particularly Turnera diffusa, as a source of treatment for various conditions is evidenced by the large number of new studies that have evaluated its biological activity. Accordingly, the objective of this review was to compile the information published in the last ten years concerning the biological activities reported for Turnera spp. The present work includes 92 publications that evaluate 29 bioactivities and toxicological and genotoxic information on five species of this genus. Among the pharmacological effects reported, the antioxidant, hepatoprotective, neuroprotective, hypoglycemic, and aphrodisiac activities seem more promising. Phytochemicals and standardized plant extracts could offer alternative therapeutic remedies for various diseases. Although several flavonoids, cyanogenic glycosides, monoterpenoids, triterpenoids, and fatty acids have been isolated for Turnera plants, future research should focus on the identification of the main active principles responsible for these pharmacological activities, as well as to perform clinical trials to support the laboratory results.
- 7 November 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (11) , 1573
Open AccessBioactivity of the Genus Turnera: A Review of the Last 10 Years
Turnera is a genus of plants whose biological activity has been widely studied. The importance of this genus, particularly Turnera diffusa, as a source of treatment for various conditions is evidenced by the large number of new studies that have evaluated its biological activity. Accordingly, the objective of this review was to compile the information published in the last ten years concerning the biological activities reported for Turnera spp. The present work includes 92 publications that evaluate 29 bioactivities and toxicological and genotoxic information on five species of this genus. Among the pharmacological effects reported, the antioxidant, hepatoprotective, neuroprotective, hypoglycemic, and aphrodisiac activities seem more promising. Phytochemicals and standardized plant extracts could offer alternative therapeutic remedies for various diseases. Although several flavonoids, cyanogenic glycosides, monoterpenoids, triterpenoids, and fatty acids have been isolated for Turnera plants, future research should focus on the identification of the main active principles responsible for these pharmacological activities, as well as to perform clinical trials to support the laboratory results.
- Open Access
Two Ways to Achieve the Same Goal—Two Validated Quantitative NMR Strategies for a Low-Abundance Natural Product in Standardized Extracts: The Case of Hepatodamianol in Turnera diffusa
The quantification of low-abundance secondary metabolites in plant extracts is an analytical problem that can be addressed by different analytical platforms, the most common being those based on chromatographic methods coupled to a high-sensitivity detection system. However, in recent years nuclear magnetic resonance (NMR) has become an analytical tool of primary choice for this type of problem because of its reliability, inherent simplicity in sample preparation, reduced analysis time, and low solvent consumption. The versatility of strategies based on quantitative NMR (qNMR), such as internal and external standards and electronic references, among others, and the need to develop validated analytical methods make it essential to compare procedures that must rigorously satisfy the analytical well-established acceptance criteria for method validation. In this work, two qNMR methods were developed for the quantification of hepatodamianol, a bioactive component of T. diffusa. The first method was based on a conventional external standard calibration, and the second one was based on the pulse length-based concentration determination (PULCON) method using the ERETIC2 module as a quantitation tool available in TopSpin software. The results show that both procedures allow the content of the analyte of interest in a complex matrix to be determined in a satisfactory way, under strict analytical criteria. In addition, ERETIC2 offers additional advantages such as a reduction in experimental time, reagent consumption, and waste generated.
Open AccessTwo Ways to Achieve the Same Goal—Two Validated Quantitative NMR Strategies for a Low-Abundance Natural Product in Standardized Extracts: The Case of Hepatodamianol in Turnera diffusa
The quantification of low-abundance secondary metabolites in plant extracts is an analytical problem that can be addressed by different analytical platforms, the most common being those based on chromatographic methods coupled to a high-sensitivity detection system. However, in recent years nuclear magnetic resonance (NMR) has become an analytical tool of primary choice for this type of problem because of its reliability, inherent simplicity in sample preparation, reduced analysis time, and low solvent consumption. The versatility of strategies based on quantitative NMR (qNMR), such as internal and external standards and electronic references, among others, and the need to develop validated analytical methods make it essential to compare procedures that must rigorously satisfy the analytical well-established acceptance criteria for method validation. In this work, two qNMR methods were developed for the quantification of hepatodamianol, a bioactive component of T. diffusa. The first method was based on a conventional external standard calibration, and the second one was based on the pulse length-based concentration determination (PULCON) method using the ERETIC2 module as a quantitation tool available in TopSpin software. The results show that both procedures allow the content of the analyte of interest in a complex matrix to be determined in a satisfactory way, under strict analytical criteria. In addition, ERETIC2 offers additional advantages such as a reduction in experimental time, reagent consumption, and waste generated.
- Open Access
- 11 April 2022
- Published by Sociedad Quimica de Mexico, A.C. in Journal of the Mexican Chemical Society
- Vol. 66 (2) , 198-220
Fabrication and Characterization of a Laboratory–Made New Coating Based on 1-Decyl-3-Methylimidazolium Tetrafluoroborate for SPME Fibers, an Exploration to its Application in Extractions by Direct-Immersion Mode
A novel coating for solid-phase microextraction (SPME) fibers was manufactured by using a mixture of 1-decyl-3methylimidazolium tetrafluoroborate ionic liquid and a commercial adhesive deposited on an etched stainless-steel support. The new coating was characterized by applying optical and electron microscopy, infrared spectroscopy and its extraction capacity was also evaluated. The extraction capacity was tested using as model analytes some pharmaceutical and personal care products (PPCPs) with different hydrophilicities. The potential use of the new fiber was evaluated through direct-immersion mode extractions and showed extraction capacity toward methylparaben, propylparaben, naproxen, diclofenac and benzophenone-3. Experimental design tools were used to study and optimize the variables that affect the extraction and desorption processes of the SPME by direct immersion. The analytical performance of proposed method was investigated under SPME procedure´s optimal conditions, coupled to a high-performance liquid chromatography-diode array detector (HPLC-DAD) method, which was developed and validated for analysis of the target PPCPs. The method of SPME by direct immersion was linear, precise and accurate. Detection and quantification limits of 0.023 to 0.093 μg mL-1 and 0.118 to 0.279 μg mL-1 were obtained, respectively. By the use of the developed method, tap water samples were analyzed and recoveries from 3.39 to 183.29 % were found. The new fiber presented an adequate stability and good extraction reproducibility (<15 % RSD). As a final point, this device is of easy and quick preparation, inexpensive, and suitable for extraction of some PPCPs. Resumen. Se fabricó un nuevo recubrimiento para fibras de microextracción en fase sólida (SPME) utilizando una mezcla del líquido iónico tetrafluoroborato de 1-decil-3metilimidazolio y un adhesivo comercial depositada sobre un soporte de acero inoxidable grabado. El nuevo recubrimiento se caracterizó mediante la aplicación de microscopía óptica y electrónica, espectroscopía de infrarrojo y también se evaluó su capacidad de extracción. La capacidad de extracción se probó utilizando como analitos modelo algunos productos farmacéuticos y de cuidado personal (PPCPs) con diferentes hidrofilicidades. El uso potencial de la nueva fibra se evaluó mediante extracciones en modo de inmersión directa y mostró capacidad de extracción hacia metilparabeno, propilparabeno, naproxeno, diclofenaco y benzofenona-3. Se utilizaron herramientas del diseño experimental para estudiar y optimizar las variables que afectan los procesos de extracción y desorción de la SPME por inmersión directa. El rendimiento analítico del método propuesto se investigó en las condiciones óptimas del procedimiento de SPME, acoplado a un método de cromatografía líquida de alto rendimiento con detector de arreglo de diodos (HPLC-DAD), que fue desarrollado y validado para el análisis de los PPCPs objetivo. El método de SPME por inmersión directa fue lineal, preciso y exacto. Se obtuvieron límites de detección y cuantificación de 0.023 a 0.093 μg mL-1 y 0.118 a 0.279 μg mL-1, respectivamente. Mediante el uso del método desarrollado, se analizaron muestras de agua del grifo y se encontraron recuperaciones de 3.39 a 183.29 %. La nueva fibra presentó una adecuada estabilidad y buena reproducibilidad de extracción (<15 % RSD). Como punto final, este dispositivo es de fácil y rápida preparación, económico y adecuado para la extracción de algunos PPCPs.
- 11 April 2022
- Published by Sociedad Quimica de Mexico, A.C. in Journal of the Mexican Chemical Society
- Vol. 66 (2) , 198-220
Open AccessFabrication and Characterization of a Laboratory–Made New Coating Based on 1-Decyl-3-Methylimidazolium Tetrafluoroborate for SPME Fibers, an Exploration to its Application in Extractions by Direct-Immersion Mode
A novel coating for solid-phase microextraction (SPME) fibers was manufactured by using a mixture of 1-decyl-3methylimidazolium tetrafluoroborate ionic liquid and a commercial adhesive deposited on an etched stainless-steel support. The new coating was characterized by applying optical and electron microscopy, infrared spectroscopy and its extraction capacity was also evaluated. The extraction capacity was tested using as model analytes some pharmaceutical and personal care products (PPCPs) with different hydrophilicities. The potential use of the new fiber was evaluated through direct-immersion mode extractions and showed extraction capacity toward methylparaben, propylparaben, naproxen, diclofenac and benzophenone-3. Experimental design tools were used to study and optimize the variables that affect the extraction and desorption processes of the SPME by direct immersion. The analytical performance of proposed method was investigated under SPME procedure´s optimal conditions, coupled to a high-performance liquid chromatography-diode array detector (HPLC-DAD) method, which was developed and validated for analysis of the target PPCPs. The method of SPME by direct immersion was linear, precise and accurate. Detection and quantification limits of 0.023 to 0.093 μg mL-1 and 0.118 to 0.279 μg mL-1 were obtained, respectively. By the use of the developed method, tap water samples were analyzed and recoveries from 3.39 to 183.29 % were found. The new fiber presented an adequate stability and good extraction reproducibility (<15 % RSD). As a final point, this device is of easy and quick preparation, inexpensive, and suitable for extraction of some PPCPs. Resumen. Se fabricó un nuevo recubrimiento para fibras de microextracción en fase sólida (SPME) utilizando una mezcla del líquido iónico tetrafluoroborato de 1-decil-3metilimidazolio y un adhesivo comercial depositada sobre un soporte de acero inoxidable grabado. El nuevo recubrimiento se caracterizó mediante la aplicación de microscopía óptica y electrónica, espectroscopía de infrarrojo y también se evaluó su capacidad de extracción. La capacidad de extracción se probó utilizando como analitos modelo algunos productos farmacéuticos y de cuidado personal (PPCPs) con diferentes hidrofilicidades. El uso potencial de la nueva fibra se evaluó mediante extracciones en modo de inmersión directa y mostró capacidad de extracción hacia metilparabeno, propilparabeno, naproxeno, diclofenaco y benzofenona-3. Se utilizaron herramientas del diseño experimental para estudiar y optimizar las variables que afectan los procesos de extracción y desorción de la SPME por inmersión directa. El rendimiento analítico del método propuesto se investigó en las condiciones óptimas del procedimiento de SPME, acoplado a un método de cromatografía líquida de alto rendimiento con detector de arreglo de diodos (HPLC-DAD), que fue desarrollado y validado para el análisis de los PPCPs objetivo. El método de SPME por inmersión directa fue lineal, preciso y exacto. Se obtuvieron límites de detección y cuantificación de 0.023 a 0.093 μg mL-1 y 0.118 a 0.279 μg mL-1, respectivamente. Mediante el uso del método desarrollado, se analizaron muestras de agua del grifo y se encontraron recuperaciones de 3.39 a 183.29 %. La nueva fibra presentó una adecuada estabilidad y buena reproducibilidad de extracción (<15 % RSD). Como punto final, este dispositivo es de fácil y rápida preparación, económico y adecuado para la extracción de algunos PPCPs.
- Open Access
- 10 January 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-10
Development of a Hepatoprotective Herbal Drug from Turnera diffusa
The incidence of liver diseases, such as nonalcoholic fatty liver disease and drug-induced liver injury, continues to rise and is one of the leading causes of acute hepatitis. Current trends suggest that these types of conditions will increase in the coming years. There are few drugs available for the prevention or treatment of hepatic diseases, and there is a growing need for the development of safe hepatoprotective agents. The medicinal plant, Turnera diffusa, has many ethnopharmacological uses, one of which is the production of a flavonoid named hepatodamianol, which is the principal component responsible for this plants hepatoprotective properties. In the present study, we describe the development and standardization of an active extract obtained from T. diffusa. We conducted nuclear magnetic resonance spectroscopy to identify hepatodamianol unambiguously in each sample. Using this extract, hepatoprotection could be demonstrated in vivo for the first time. The hepatoprotective effect did not display a significant difference in vivo when compared with silymarin used as a positive control at the same doses. Implementation of quality criteria used for standardization, such as flavonoid and hepatodamianol content, hepatoprotective activity, and absence of residual solvents, will allow future preclinical trials with this herbal drug.
- 10 January 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-10
Open AccessDevelopment of a Hepatoprotective Herbal Drug from Turnera diffusa
The incidence of liver diseases, such as nonalcoholic fatty liver disease and drug-induced liver injury, continues to rise and is one of the leading causes of acute hepatitis. Current trends suggest that these types of conditions will increase in the coming years. There are few drugs available for the prevention or treatment of hepatic diseases, and there is a growing need for the development of safe hepatoprotective agents. The medicinal plant, Turnera diffusa, has many ethnopharmacological uses, one of which is the production of a flavonoid named hepatodamianol, which is the principal component responsible for this plants hepatoprotective properties. In the present study, we describe the development and standardization of an active extract obtained from T. diffusa. We conducted nuclear magnetic resonance spectroscopy to identify hepatodamianol unambiguously in each sample. Using this extract, hepatoprotection could be demonstrated in vivo for the first time. The hepatoprotective effect did not display a significant difference in vivo when compared with silymarin used as a positive control at the same doses. Implementation of quality criteria used for standardization, such as flavonoid and hepatodamianol content, hepatoprotective activity, and absence of residual solvents, will allow future preclinical trials with this herbal drug.
- Open Access
Active Flavonoids from Colubrina greggii var. greggii S. Watson against Clinical Isolates of Candida spp.
Candida albicans is the most commonly implicated agent in invasive human fungal infections. The disease could be presented as minimal symptomatic candidemia or can be fulminant sepsis. Candidemia is associated with a high rate of mortality and high healthcare and hospitalization costs. The surveillance programs have reported the distribution of other Candida species reflecting the trends and antifungal susceptibilities. Previous studies have demonstrated that C. glabrata more frequently presents fluconazole-resistant strains. Extracts from Mexican plants have been reported with activity against pulmonary mycosis, among them Colubrina greggii. In the present study, extracts from the aerial parts (leaves, flowers, and fruits) of this plant were evaluated against clinical isolates of several species of Candida (C. albicans, C. glabrata, C. parapsilosis, C. krusei, and C. tropicalis) by the broth microdilution assay. Through bioassay-guided fractionation, three antifungal glycosylated flavonoids were isolated and characterized. The isolated compounds showed antifungal activity only against C. glabrata resistant to fluconazole, and were non-toxic toward brine shrimp lethality bioassay and in vitro Vero cell line assay. The ethyl acetate and butanol extracts, as well as the fractions containing the mixture of flavonoids, were more active against Candida spp.
Open AccessActive Flavonoids from Colubrina greggii var. greggii S. Watson against Clinical Isolates of Candida spp.
Candida albicans is the most commonly implicated agent in invasive human fungal infections. The disease could be presented as minimal symptomatic candidemia or can be fulminant sepsis. Candidemia is associated with a high rate of mortality and high healthcare and hospitalization costs. The surveillance programs have reported the distribution of other Candida species reflecting the trends and antifungal susceptibilities. Previous studies have demonstrated that C. glabrata more frequently presents fluconazole-resistant strains. Extracts from Mexican plants have been reported with activity against pulmonary mycosis, among them Colubrina greggii. In the present study, extracts from the aerial parts (leaves, flowers, and fruits) of this plant were evaluated against clinical isolates of several species of Candida (C. albicans, C. glabrata, C. parapsilosis, C. krusei, and C. tropicalis) by the broth microdilution assay. Through bioassay-guided fractionation, three antifungal glycosylated flavonoids were isolated and characterized. The isolated compounds showed antifungal activity only against C. glabrata resistant to fluconazole, and were non-toxic toward brine shrimp lethality bioassay and in vitro Vero cell line assay. The ethyl acetate and butanol extracts, as well as the fractions containing the mixture of flavonoids, were more active against Candida spp.
- Open Access
- 26 July 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-9
Anti-inflammatory and nephroprotective activity of Juglans mollis against renal ischemia–reperfusion damage in a Wistar rat model
Oxidative stress and the inflammatory process are involved in ischemia–reperfusion (I/R) injury. Juglans mollis has been reported as having antioxidant activity, which could attenuate the damage caused by I/R. We evaluated whether a methanolic extract of Juglans mollis (JM) exhibits nephroprotective activity in a Wistar rat model of I/R injury. Four groups of six rats were used: Sham, I/R, JM, and JM + I/R. Two groups were dosed with JM (300 mg/kg) for 7 days before I/R. I/R injury was induced by clamping the renal hilums for 45 min and then reperfusing the kidneys for 15 h. Blood samples were taken to evaluate the levels of alanine aminotransferase (ALT), blood urea nitrogen, creatinine, superoxide dismutase (SOD), malondialdehyde (MDA), interleukin 1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α). The levels of creatinine, ALT, MDA, IL-1β, IL-6, and TNF-α were lower in JM + I/R than in I/R rats, whereas SOD level only was higher in JM + I/R than in Sham rats. No biochemical or histological damage was observed in JM rats compared with Sham rats; however, less histological damage was observed in JM + I/R rats compared with I/R rats. To our knowledge, this is the first report of nephroprotective activity of J. mollis against damage induced by I/R. This activity may be related to decreased levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and modulation of oxidative stress markers (SOD and MDA) observed in the present study.
- 26 July 2019
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 19 (1) , 1-9
Open AccessAnti-inflammatory and nephroprotective activity of Juglans mollis against renal ischemia–reperfusion damage in a Wistar rat model
Oxidative stress and the inflammatory process are involved in ischemia–reperfusion (I/R) injury. Juglans mollis has been reported as having antioxidant activity, which could attenuate the damage caused by I/R. We evaluated whether a methanolic extract of Juglans mollis (JM) exhibits nephroprotective activity in a Wistar rat model of I/R injury. Four groups of six rats were used: Sham, I/R, JM, and JM + I/R. Two groups were dosed with JM (300 mg/kg) for 7 days before I/R. I/R injury was induced by clamping the renal hilums for 45 min and then reperfusing the kidneys for 15 h. Blood samples were taken to evaluate the levels of alanine aminotransferase (ALT), blood urea nitrogen, creatinine, superoxide dismutase (SOD), malondialdehyde (MDA), interleukin 1β (IL-1β), IL-6, and tumor necrosis factor α (TNF-α). The levels of creatinine, ALT, MDA, IL-1β, IL-6, and TNF-α were lower in JM + I/R than in I/R rats, whereas SOD level only was higher in JM + I/R than in Sham rats. No biochemical or histological damage was observed in JM rats compared with Sham rats; however, less histological damage was observed in JM + I/R rats compared with I/R rats. To our knowledge, this is the first report of nephroprotective activity of J. mollis against damage induced by I/R. This activity may be related to decreased levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) and modulation of oxidative stress markers (SOD and MDA) observed in the present study.
- Open Access
- 26 January 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (3) , 410
Synthesis, Biological Evaluation and Docking Studies of Chalcone and Flavone Analogs as Antioxidants and Acetylcholinesterase Inhibitors
Several oxidative processes are related to a wide range of human chronic and degenerative diseases, like Alzheimer’s disease, which also has been related to cholinergic processes. Therefore, search for new or improved antioxidant molecules with acetylcholinesterase activity is essential to offer alternative chemotherapeutic agents to support current drug therapies. A series of chalcone (2a–2k) and flavone (3a–3k) analogs were synthesized, characterized, and evaluated as acetylcholinesterase (AChE) inhibitors, and antioxidant agents using 1,1-diphenyl-2-picrylhydrazyl (DPPH•), 2-2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonate) (ABTS•), and β-carotene/linoleic acid bleaching assay. Compounds more active were 3j and 2k in DPPH with EC50 of 1 × 10−8 and 5.4 × 10−3 μg/mL, respectively; 2g and 3i in ABTS (1.14 × 10−2 and 1.9 × 10−3 μg/mL); 2e, 2f, 3f, 2j, and 3j exceeded the α-tocopherol control in the β-carotene assay (98–99% of antioxidant activity). At acetylcholinesterase inhibition assay, flavones were more active than chalcones; the best results were compounds 2d and 3d (IC50 21.5 and 26.8 µg/mL, respectively), suggesting that the presence of the nitro group enhances the inhibitory activity. The docking of these two structures were made to understand their interactions with the AChE receptor. Although further in vivo testing must be performed, our results represent an important step towards the identification of improved antioxidants and acetylcholinesterase inhibitors.
- 26 January 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (3) , 410
Open AccessSynthesis, Biological Evaluation and Docking Studies of Chalcone and Flavone Analogs as Antioxidants and Acetylcholinesterase Inhibitors
Several oxidative processes are related to a wide range of human chronic and degenerative diseases, like Alzheimer’s disease, which also has been related to cholinergic processes. Therefore, search for new or improved antioxidant molecules with acetylcholinesterase activity is essential to offer alternative chemotherapeutic agents to support current drug therapies. A series of chalcone (2a–2k) and flavone (3a–3k) analogs were synthesized, characterized, and evaluated as acetylcholinesterase (AChE) inhibitors, and antioxidant agents using 1,1-diphenyl-2-picrylhydrazyl (DPPH•), 2-2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonate) (ABTS•), and β-carotene/linoleic acid bleaching assay. Compounds more active were 3j and 2k in DPPH with EC50 of 1 × 10−8 and 5.4 × 10−3 μg/mL, respectively; 2g and 3i in ABTS (1.14 × 10−2 and 1.9 × 10−3 μg/mL); 2e, 2f, 3f, 2j, and 3j exceeded the α-tocopherol control in the β-carotene assay (98–99% of antioxidant activity). At acetylcholinesterase inhibition assay, flavones were more active than chalcones; the best results were compounds 2d and 3d (IC50 21.5 and 26.8 µg/mL, respectively), suggesting that the presence of the nitro group enhances the inhibitory activity. The docking of these two structures were made to understand their interactions with the AChE receptor. Although further in vivo testing must be performed, our results represent an important step towards the identification of improved antioxidants and acetylcholinesterase inhibitors.
- Open Access
Biological Activities of Extracts from Aerial Parts of Salvia pachyphylla Epling Ex Munz
The antioxidant, antimicrobial, antiproliferative, and enzyme inhibitory properties of five extracts from aerial parts of Salvia pachyphylla Epling ex Munz were examined to assess the prospective of this plant as a source of natural products with therapeutic potential. These properties were analyzed by performing a set of standard assays. The extract obtained with dichloromethane showed the most variety of components, as they yielded promising results in all completed assays. Furthermore, the extract obtained with ethyl acetate exhibited the greatest antioxidant activity, as well as the best xanthine oxidase inhibitory activity. Remarkably, both extracts obtained with n-hexane or dichloromethane revealed significant antimicrobial activity against the Gram-positive bacteria; additionally, they showed greater antiproliferative activity against three representative cell lines of the most common types of cancers in women worldwide, and against a cell line that exemplifies cancers that typically develop drug resistance. Despite that, other extracts were less active, such as the methanolic or aqueous; their results are promising for the isolation and identification of novel bioactive molecules.
Open AccessBiological Activities of Extracts from Aerial Parts of Salvia pachyphylla Epling Ex Munz
The antioxidant, antimicrobial, antiproliferative, and enzyme inhibitory properties of five extracts from aerial parts of Salvia pachyphylla Epling ex Munz were examined to assess the prospective of this plant as a source of natural products with therapeutic potential. These properties were analyzed by performing a set of standard assays. The extract obtained with dichloromethane showed the most variety of components, as they yielded promising results in all completed assays. Furthermore, the extract obtained with ethyl acetate exhibited the greatest antioxidant activity, as well as the best xanthine oxidase inhibitory activity. Remarkably, both extracts obtained with n-hexane or dichloromethane revealed significant antimicrobial activity against the Gram-positive bacteria; additionally, they showed greater antiproliferative activity against three representative cell lines of the most common types of cancers in women worldwide, and against a cell line that exemplifies cancers that typically develop drug resistance. Despite that, other extracts were less active, such as the methanolic or aqueous; their results are promising for the isolation and identification of novel bioactive molecules.
- Open Access
Acute Hypoglycemic and Antidiabetic Effect of Teuhetenone A Isolated from Turnera diffusa
Diabetes mellitus is a chronic degenerative disease that causes long-term complications and represents a serious public health problem. Turnera diffusa (damiana) is a shrub that grows throughout Mexico and is traditionally used for many illnesses including diabetes. Although a large number of plant metabolites are known, there are no reports indicating which of these are responsible for this activity, and this identification was the objective of the present work. Through bioassay-guided fractionation of a methanolic extract obtained from the aerial part of T. diffusa, teuhetenone A was isolated and identified as the main metabolite responsible for the plant’s hypoglycemic activity. Alpha-glucosidase inhibitory activity and cytotoxicity of this metabolite were determined. Hypoglycemic and antidiabetic activities were evaluated in a murine model of diabetes in vivo, by monitoring glucose levels for six hours and comparing them with levels after administering various controls. Teuhetenone A was not cytotoxic at the tested concentrations, and did not show inhibitory activity in the glucosidase test, and the in vivo assays showed a gradual reduction in glucose levels in normoglycemic and diabetic mice. Considering these results, we suggest that teuhetenone A has potential as an antidiabetic compound, which could be further submitted to preclinical assays.
Open AccessAcute Hypoglycemic and Antidiabetic Effect of Teuhetenone A Isolated from Turnera diffusa
Diabetes mellitus is a chronic degenerative disease that causes long-term complications and represents a serious public health problem. Turnera diffusa (damiana) is a shrub that grows throughout Mexico and is traditionally used for many illnesses including diabetes. Although a large number of plant metabolites are known, there are no reports indicating which of these are responsible for this activity, and this identification was the objective of the present work. Through bioassay-guided fractionation of a methanolic extract obtained from the aerial part of T. diffusa, teuhetenone A was isolated and identified as the main metabolite responsible for the plant’s hypoglycemic activity. Alpha-glucosidase inhibitory activity and cytotoxicity of this metabolite were determined. Hypoglycemic and antidiabetic activities were evaluated in a murine model of diabetes in vivo, by monitoring glucose levels for six hours and comparing them with levels after administering various controls. Teuhetenone A was not cytotoxic at the tested concentrations, and did not show inhibitory activity in the glucosidase test, and the in vivo assays showed a gradual reduction in glucose levels in normoglycemic and diabetic mice. Considering these results, we suggest that teuhetenone A has potential as an antidiabetic compound, which could be further submitted to preclinical assays.